Literature DB >> 7814533

Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans.

Y Rikihisa1, S A Ewing, J C Fox.   

Abstract

Ehrlichia chaffeensis, E. canis, and E. ewingii are genetically closely related, as determined by 16S rRNA gene base sequence comparison, but they exhibit biologic differences. E. chaffeensis is the etiologic agent of human ehrlichiosis. E. canis and E. ewingii cause two distinctly different forms of canine ehrlichiosis and infect different types of leukocytes, monocytes and granulocytes, respectively. E. chaffeensis can also infect dogs. In the study, Western immunoblot analysis of sera from dogs inoculated with E. chaffeensis, E. canis, or E. ewingii was performed to determine antigenic specificity and the intensities of the reactions to purified E. chaffeensis and E. canis antigens. At 2 to 3 weeks postexposure, antisera from four dogs inoculated with E. chaffeensis reacted with 64-, 47-, 31-, and 29-kDa proteins of E. chaffeensis but reacted poorly with E. canis antigen. In contrast, at 2 to 3 weeks postexposure, antisera from four E. canis-inoculated dogs reacted strongly with the 30-kDa major antigen of E. canis but reacted poorly with proteins from E. chaffeensis. At 4 weeks postexposure, the sera from three E. ewingii-inoculated dogs showed weak binding to 64- and 47-kDa proteins of both E. chaffeensis and E. canis. Convalescent-phase sera from human ehrlichiosis patients and sera from dogs chronically infected with E. ewingii strongly reacted with similar sets of proteins of E. chaffeensis and E. canis with similar intensities. However, sera from dogs chronically infected with E. canis reacted more strongly with a greater number of E. canis proteins than with E. chaffeensis proteins. The protein specificity described in the report suggests that dogs with E. canis infections can be distinguished from E. chaffeensis-infected animals by Western immunoblot analysis with both E. canis and E. chaffeensis antigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814533      PMCID: PMC263951          DOI: 10.1128/jcm.32.9.2107-2112.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

2.  Distribution of Ehrlichia canis among military working dogs in the world and selected civilian dogs in the United States.

Authors:  T J Keefe; C J Holland; P E Salyer; M Ristic
Journal:  J Am Vet Med Assoc       Date:  1982-08-01       Impact factor: 1.936

Review 3.  Ehrlichiosis--a disease of animals and humans.

Authors:  J E McDade
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

Review 4.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

6.  Cross-reacting antigens between Neorickettsia helminthoeca and Ehrlichia species, shown by immunofluorescence and Western immunoblotting.

Authors:  Y Rikihisa
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

7.  C-reactive protein and alpha 1-acid glycoprotein levels in dogs infected with Ehrlichia canis.

Authors:  Y Rikihisa; S Yamamoto; I Kwak; Z Iqbal; G Kociba; J Mott; W Chichanasiriwithaya
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  Analyses of Ehrlichia canis and a canine granulocytic Ehrlichia infection.

Authors:  Y Rikihisa; S A Ewing; J C Fox; A G Siregar; F H Pasaribu; M B Malole
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates.

Authors:  J E Dawson; Y Rikihisa; S A Ewing; D B Fishbein
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  53 in total

Review 1.  Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis.

Authors:  S Harrus; T Waner; H Bark; F Jongejan; A W Cornelissen
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Molecular cloning of the gene for a conserved major immunoreactive 28-kilodalton protein of Ehrlichia canis: a potential serodiagnostic antigen.

Authors:  J W McBride; X j Yu; D H Walker
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

4.  Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis.

Authors:  N Zhi; Y Rikihisa; H Y Kim; G P Wormser; H W Horowitz
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Transcriptional analysis of p30 major outer membrane protein genes of Ehrlichia canis in naturally infected ticks and sequence analysis of p30-10 of E canis from diverse geographic regions.

Authors:  Suleyman Felek; Russell Greene; Yasuko Rikihisa
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis.

Authors:  N Zhi; N Ohashi; Y Rikihisa; H W Horowitz; G P Wormser; K Hechemy
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  Cloning and characterization of multigenes encoding the immunodominant 30-kilodalton major outer membrane proteins of Ehrlichia canis and application of the recombinant protein for serodiagnosis.

Authors:  N Ohashi; A Unver; N Zhi; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Comparison of serological detection methods for diagnosis of Ehrlichia canis infections in dogs.

Authors:  Myriam Bélanger; Heather L Sorenson; Michelle K France; Michael V Bowie; Anthony F Barbet; Edward B Breitschwerdt; A Rick Alleman
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Mass spectrometric analysis of Ehrlichia chaffeensis tandem repeat proteins reveals evidence of phosphorylation and absence of glycosylation.

Authors:  Abdul Wakeel; Xiaofeng Zhang; Jere W McBride
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

10.  Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Authors:  Quan Lin; Ning Zhi; Norio Ohashi; Harold W Horowitz; Maria E Aguero-Rosenfeld; John Raffalli; Gary P Wormser; Yasuko Rikihisa
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.